Breast-cancer adjuvant therapy with zoledronic acid REPLY

MLA

Coleman, Re, et al. Breast-Cancer Adjuvant Therapy with Zoledronic Acid REPLY. Jan. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.core.ac.uk....2db2efdb5b8395ba975349db260a9c3b&authtype=sso&custid=ns315887.

APA

Coleman, R., Marshall, H., Bell, R., & on behalf of the AZURE Investigators. (2012). Breast-cancer adjuvant therapy with zoledronic acid REPLY.

Chicago

Coleman, Re, H Marshall, R Bell, and on behalf of the AZURE Investigators. 2012. “Breast-Cancer Adjuvant Therapy with Zoledronic Acid REPLY,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.core.ac.uk....2db2efdb5b8395ba975349db260a9c3b&authtype=sso&custid=ns315887.